US stocks managed to eke out gains on Monday as bond yields eased off bigger gains and Wall Street largely shrugged off Moody's downgrade of the US credit rating. Meanwhile, investors digested ...

This revolution is being powered by RNA technology — and Canada is uniquely positioned to lead it. While the swift development of COVID-19 vaccines appeared to be a sudden scientific triumph ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

Novavax's vaccine, which was approved by Health Canada for adults and children 12 years and older, has been touted as an alternative to mRNA vaccines Author of the article: You can save this ...

Canada is donating “up to 200,000” doses of mpox vaccine, a government spokesperson said on Wednesday. This comes after the World Health Organization declared mpox a global health emergency ...

Its stock dropped dramatically after it failed to make substantial inroads with its vaccine. Company picked by Ottawa to produce made-in-Canada vaccines warns it may go out of business But ...

Novavax got a big cash infusion with the Sanofi deal, and will now move into flu vaccines Novavax Inc (NASDAQ:NVAX) stock is up 130% to trade at $10.82 today, by far the best stock on the Nasdaq ...

In an effort to get COVID-19 vaccines made in Canada, the federal government announced in February 2021 a deal between the National Research Council’s (NRC) Biologics Manufacturing Centre (BMC) ...

Pfizer faces declining vaccine revenue and patent expirations ... but don't let that dissuade you from considering this blue-chip stock for your portfolio. The company's giant cash hoard gives ...